Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1987 Nov;63(745):931–935. doi: 10.1136/pgmj.63.745.931

Lymphocyte subpopulations.

R J Powell 1, J S Jenkins 1
PMCID: PMC2428713  PMID: 3330231

Full text

PDF
931

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisenberg A. C., Krontiris T. G., Mak T. W., Wilkes B. M. Rearrangement of the gene for the beta chain of the T-cell receptor in T-cell chronic lymphocytic leukemia and related disorders. N Engl J Med. 1985 Aug 29;313(9):529–533. doi: 10.1056/NEJM198508293130901. [DOI] [PubMed] [Google Scholar]
  2. Bottazzo G. F., Dean B. M., McNally J. M., MacKay E. H., Swift P. G., Gamble D. R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med. 1985 Aug 8;313(6):353–360. doi: 10.1056/NEJM198508083130604. [DOI] [PubMed] [Google Scholar]
  3. Buschard K., Madsbad S., Rygaard J. Depressed suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus. Clin Exp Immunol. 1980 Jul;41(1):25–32. [PMC free article] [PubMed] [Google Scholar]
  4. Cosimi A. B., Colvin R. B., Burton R. C., Rubin R. H., Goldstein G., Kung P. C., Hansen W. P., Delmonico F. L., Russell P. S. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med. 1981 Aug 6;305(6):308–314. doi: 10.1056/NEJM198108063050603. [DOI] [PubMed] [Google Scholar]
  5. Fingeroth J. D., Weis J. J., Tedder T. F., Strominger J. L., Biro P. A., Fearon D. T. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A. 1984 Jul;81(14):4510–4514. doi: 10.1073/pnas.81.14.4510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Foon K. A., Schroff R. W., Gale R. P. Surface markers on leukemia and lymphoma cells: recent advances. Blood. 1982 Jul;60(1):1–19. [PubMed] [Google Scholar]
  7. Galluzzo A., Giordano C., Rubino G., Bompiani G. D. Immunoregulatory T-lymphocyte subset deficiency in newly diagnosed type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1984 Jun;26(6):426–430. doi: 10.1007/BF00262214. [DOI] [PubMed] [Google Scholar]
  8. Horita M., Suzuki H., Onodera T., Ginsberg-Fellner F., Fauci A. S., Notkins A. L. Abnormalities of immunoregulatory T cell subsets in patients with insulin-dependent diabetes mellitus. J Immunol. 1982 Oct;129(4):1426–1429. [PubMed] [Google Scholar]
  9. Jackson R. A., Morris M. A., Haynes B. F., Eisenbarth G. S. Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. N Engl J Med. 1982 Apr 1;306(13):785–788. doi: 10.1056/NEJM198204013061305. [DOI] [PubMed] [Google Scholar]
  10. Lanier L. L., Le A. M., Phillips J. H., Warner N. L., Babcock G. F. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol. 1983 Oct;131(4):1789–1796. [PubMed] [Google Scholar]
  11. Loveland B. E., McKenzie I. F. Which T cells cause graft rejection? Transplantation. 1982 Mar;33(3):217–221. doi: 10.1097/00007890-198203000-00001. [DOI] [PubMed] [Google Scholar]
  12. Morimoto C., Reinherz E. L., Distaso J. A., Steinberg A. D., Schlossman S. F. Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions. J Clin Invest. 1984 Mar;73(3):689–700. doi: 10.1172/JCI111261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Pinching A. J., Weiss R. A. AIDS and the spectrum of HTLV-III/LAV infection. Int Rev Exp Pathol. 1986;28:1–44. [PubMed] [Google Scholar]
  14. Polk B. F., Fox R., Brookmeyer R., Kanchanaraksa S., Kaslow R., Visscher B., Rinaldo C., Phair J. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med. 1987 Jan 8;316(2):61–66. doi: 10.1056/NEJM198701083160201. [DOI] [PubMed] [Google Scholar]
  15. Pontesilli O., Chase H. P., Carotenuto P., Herberger M. J., Hayward A. R. T-lymphocyte subpopulations in insulin-dependent (type I) diabetes mellitus. Clin Exp Immunol. 1986 Jan;63(1):68–72. [PMC free article] [PubMed] [Google Scholar]
  16. Pozzilli P., Zuccarini O., Iavicoli M., Andreani D., Sensi M., Spencer K. M., Bottazzo G. F., Beverley P. C., Kyner J. L., Cudworth A. G. Monoclonal antibodies defined abnormalities of T-lymphocytes in type I (insulin-dependent) diabetes. Diabetes. 1983 Jan;32(1):91–94. doi: 10.2337/diab.32.1.91. [DOI] [PubMed] [Google Scholar]
  17. Prentice H. G., Blacklock H. A., Janossy G., Gilmore M. J., Price-Jones L., Tidman N., Trejdosiewicz L. K., Skeggs D. B., Panjwani D., Ball S. Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet. 1984 Mar 3;1(8375):472–476. doi: 10.1016/s0140-6736(84)92848-4. [DOI] [PubMed] [Google Scholar]
  18. Sakane T., Kotani H., Takada S., Murakawa Y., Ueda Y. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function. J Immunol. 1983 Aug;131(2):753–761. [PubMed] [Google Scholar]
  19. Stohl W., Crow M. K., Kunkel H. G. Systemic lupus erythematosus with deficiency of the T4 epitope on T helper/inducer cells. N Engl J Med. 1985 Jun 27;312(26):1671–1678. doi: 10.1056/NEJM198506273122604. [DOI] [PubMed] [Google Scholar]
  20. Suzuki H., Sakurami T., Imura H. Relationship between reduced B cell susceptibility to IgM antibodies and reduced IgD-bearing B cells in patients with systemic lupus erythematosus. Arthritis Rheum. 1982 Dec;25(12):1451–1459. doi: 10.1002/art.1780251211. [DOI] [PubMed] [Google Scholar]
  21. Takahashi H., Okazaki H., Terasaki P. I., Iwaki Y., Kinukawa T., Taguchi Y., Chia D., Hardiwidjaja S., Miura K., Ishizaki M. Reversal of transplant rejection by monoclonal antiblast antibody. Lancet. 1983 Nov 19;2(8360):1155–1158. doi: 10.1016/s0140-6736(83)91212-6. [DOI] [PubMed] [Google Scholar]
  22. Thistlethwaite J. R., Jr, Haag B. W., Gaber A. O., Stuart J. K., Aronson A. J., Mayes J. T., Lloyd D. M., Stuart F. P. The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine. Transplant Proc. 1987 Feb;19(1 Pt 3):1901–1904. [PubMed] [Google Scholar]
  23. Waldmann H., Polliak A., Hale G., Or R., Cividalli G., Weiss L., Weshler Z., Samuel S., Manor D., Brautbar C. Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1). Lancet. 1984 Sep 1;2(8401):483–486. doi: 10.1016/s0140-6736(84)92564-9. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES